EMPLI Stock Overview
Emplicure AB (publ) engages in the research and development of pharmaceutical products primarily for the treatment of chronic pain in Sweden.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Emplicure AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr0.47 |
| 52 Week High | kr1.53 |
| 52 Week Low | kr0.34 |
| Beta | 1.32 |
| 1 Month Change | 13.25% |
| 3 Month Change | 28.42% |
| 1 Year Change | -68.46% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -86.17% |
Recent News & Updates
Recent updates
Shareholder Returns
| EMPLI | SE Pharmaceuticals | SE Market | |
|---|---|---|---|
| 7D | 9.3% | -5.7% | -1.6% |
| 1Y | -68.5% | 58.1% | 7.8% |
Return vs Industry: EMPLI underperformed the Swedish Pharmaceuticals industry which returned 28.5% over the past year.
Return vs Market: EMPLI underperformed the Swedish Market which returned 5.8% over the past year.
Price Volatility
| EMPLI volatility | |
|---|---|
| EMPLI Average Weekly Movement | 13.3% |
| Pharmaceuticals Industry Average Movement | 6.2% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in SE Market | 12.8% |
| 10% least volatile stocks in SE Market | 3.4% |
Stable Share Price: EMPLI has not had significant price volatility in the past 3 months.
Volatility Over Time: EMPLI's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | n/a | Hakan Engqvist | emplicure.com |
Emplicure AB (publ) engages in the research and development of pharmaceutical products primarily for the treatment of chronic pain in Sweden. It provides Empli03, an oral buccal tablet; and Amp01, an oral nicotine pouche. The company was incorporated in 2014 and is based in Uppsala, Sweden.
Emplicure AB (publ) Fundamentals Summary
| EMPLI fundamental statistics | |
|---|---|
| Market cap | kr46.47m |
| Earnings (TTM) | -kr27.31m |
| Revenue (TTM) | n/a |
-339.2x
P/S Ratio-1.7x
P/E RatioIs EMPLI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EMPLI income statement (TTM) | |
|---|---|
| Revenue | -kr137.00k |
| Cost of Revenue | kr769.00k |
| Gross Profit | -kr906.00k |
| Other Expenses | kr26.41m |
| Earnings | -kr27.31m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.28 |
| Gross Margin | 661.31% |
| Net Profit Margin | 19,935.04% |
| Debt/Equity Ratio | 0% |
How did EMPLI perform over the long term?
See historical performance and comparison